PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CZMWY vs. SCHD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CZMWY and SCHD is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CZMWY vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Carl Zeiss Meditec AG ADR (CZMWY) and Schwab US Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-15.98%
5.07%
CZMWY
SCHD

Key characteristics

Sharpe Ratio

CZMWY:

-1.09

SCHD:

1.27

Sortino Ratio

CZMWY:

-1.58

SCHD:

1.87

Omega Ratio

CZMWY:

0.80

SCHD:

1.22

Calmar Ratio

CZMWY:

-0.64

SCHD:

1.82

Martin Ratio

CZMWY:

-1.16

SCHD:

4.66

Ulcer Index

CZMWY:

43.96%

SCHD:

3.11%

Daily Std Dev

CZMWY:

46.87%

SCHD:

11.39%

Max Drawdown

CZMWY:

-79.76%

SCHD:

-33.37%

Current Drawdown

CZMWY:

-74.54%

SCHD:

-3.20%

Returns By Period

In the year-to-date period, CZMWY achieves a 22.44% return, which is significantly higher than SCHD's 3.66% return. Over the past 10 years, CZMWY has underperformed SCHD with an annualized return of 10.46%, while SCHD has yielded a comparatively higher 11.25% annualized return.


CZMWY

YTD

22.44%

1M

13.73%

6M

-15.98%

1Y

-50.71%

5Y*

-12.41%

10Y*

10.46%

SCHD

YTD

3.66%

1M

0.35%

6M

5.08%

1Y

14.02%

5Y*

11.76%

10Y*

11.25%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CZMWY vs. SCHD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CZMWY
The Risk-Adjusted Performance Rank of CZMWY is 88
Overall Rank
The Sharpe Ratio Rank of CZMWY is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of CZMWY is 44
Sortino Ratio Rank
The Omega Ratio Rank of CZMWY is 55
Omega Ratio Rank
The Calmar Ratio Rank of CZMWY is 1111
Calmar Ratio Rank
The Martin Ratio Rank of CZMWY is 1717
Martin Ratio Rank

SCHD
The Risk-Adjusted Performance Rank of SCHD is 5252
Overall Rank
The Sharpe Ratio Rank of SCHD is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of SCHD is 5353
Sortino Ratio Rank
The Omega Ratio Rank of SCHD is 4949
Omega Ratio Rank
The Calmar Ratio Rank of SCHD is 6161
Calmar Ratio Rank
The Martin Ratio Rank of SCHD is 4747
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CZMWY vs. SCHD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Carl Zeiss Meditec AG ADR (CZMWY) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CZMWY, currently valued at -1.09, compared to the broader market-2.000.002.00-1.091.27
The chart of Sortino ratio for CZMWY, currently valued at -1.58, compared to the broader market-4.00-2.000.002.004.006.00-1.581.87
The chart of Omega ratio for CZMWY, currently valued at 0.80, compared to the broader market0.501.001.502.000.801.22
The chart of Calmar ratio for CZMWY, currently valued at -0.64, compared to the broader market0.002.004.006.00-0.641.82
The chart of Martin ratio for CZMWY, currently valued at -1.16, compared to the broader market-10.000.0010.0020.0030.00-1.164.66
CZMWY
SCHD

The current CZMWY Sharpe Ratio is -1.09, which is lower than the SCHD Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of CZMWY and SCHD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-1.09
1.27
CZMWY
SCHD

Dividends

CZMWY vs. SCHD - Dividend Comparison

CZMWY's dividend yield for the trailing twelve months is around 2.05%, less than SCHD's 3.51% yield.


TTM20242023202220212020201920182017201620152014
CZMWY
Carl Zeiss Meditec AG ADR
2.05%2.51%1.08%0.79%0.29%1.09%0.49%0.84%0.74%1.18%1.52%2.35%
SCHD
Schwab US Dividend Equity ETF
3.51%3.64%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%2.63%

Drawdowns

CZMWY vs. SCHD - Drawdown Comparison

The maximum CZMWY drawdown since its inception was -79.76%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for CZMWY and SCHD. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-74.54%
-3.20%
CZMWY
SCHD

Volatility

CZMWY vs. SCHD - Volatility Comparison

Carl Zeiss Meditec AG ADR (CZMWY) has a higher volatility of 18.97% compared to Schwab US Dividend Equity ETF (SCHD) at 3.27%. This indicates that CZMWY's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
18.97%
3.27%
CZMWY
SCHD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab